FAP and neoplasm: In a study on resistance to ICB immunotherapy (pembrolizumab) in metastatic GC, FAP+ CAFs were found to correlate positively with MDSCs in tumor tissues, mediating an immunosuppressive barrier through enhanced MDSC infiltration [197].